Scientists learn what's 'up' with a class of retinal cells in mice

Harvard University researchers have discovered a new type of retinal cell that plays an exclusive and unusual role in mice: detecting upward motion. The cells reflect their function in the physical arrangement of their dendrites, branch-like structures on neuronal cells that form a communicative network with other dendrites and neurons in the brain.

The work, led by neuroscientists Joshua R. Sanes and Markus Meister, is described this week in the journal Nature.

"The structure of these cells resembles the photos you see in the aftermath of a hurricane, where all the trees have fallen down in the same direction," says Meister, the Jeff C. Tarr Professor of Molecular and Cellular Biology in Harvard's Faculty of Arts and Sciences. "When you look at these neurons in the microscope, they all point the same way. There’s no other cell type in the retina that has that degree of directionality."

The cells, like other retinal neurons, are composed of a round cell body surrounded by a tangle of dendrites. Most retinal neurons distribute their dendrites evenly around the cell body, but the upward motion-detecting cells arrange almost 90 percent of their dendrite tangle exclusively on one side of the cell body.

"This lopsided arrangement literally directs the cell's function, orienting the dendrites downward like roots of great trees," says Sanes, professor of molecular and cellular biology and Paul J. Finnegan Family Director of Harvard's Center for Brain Science. "Because the eye's lens acts as a camera, reversing incoming light rays as they strike the retinal tissue, an object moving up will result in a downward-moving image at the back of the eye -- the exact orientation of the cells' dendrites."

The research builds on efforts by Meister to understand neural processing in the retina, as well as work in Sanes's laboratory to identify and mark neurons in the retina using molecular tags. Recently, they tracked down a family of molecules expressed exclusively by small subsets of retinal cells in mice. One in particular, called JAM-B, was present in cells that had a peculiar distribution and orientation.

According to Sanes, developmental neurologists have long tried to identify different types of neural cells based on their function and anatomy -- how they appeared on the outside.

"But it's a huge limitation because it's essentially a qualitative assessment," he says. "We really need some way to reliably identify and track these cells if we ever hope to study their development. So the emergence of cell-specific molecular markers is a very big deal, because it will do just that. Already we've seen that it helps us identify new kinds of cells we didn't know existed before. Once we have a promising molecule, we can track down the cells that it corresponds to."

"The other important result," continues Sanes, "is that we're actually mimicking how the brain itself identifies its cells. The brain has to be able to reliably recognize and tell apart different kinds of cells, and that's going to happen on a molecular basis. In fact, it’s possible that some of the molecules we've identified are, in fact, the same molecules the brain uses to distinguish cell types."

By identifying molecules that are solely expressed by specific types of neurons, scientists hope to gain insights into how nerve cells form synapses, or connections, with other nerve cells -- in short, how the brain controls its development on a molecular basis.

For the moment, however, researchers are busy puzzling over the results of the JAM-B mouse retinal cells.

"Why in the world would mice need to develop cells to detect upward motion"" Sanes wonders. "It's a great mystery."

Source: Harvard University

Related stories:

Scientists pinpoint key proteins in blood stem cell replication
A family of cancer-fighting molecules helps blood stem cells in mice decide when and how to divide, say researchers at the Stanford University School of Medicine. Blocking the molecules' function spurs the normally resting cells to begin proliferating strangely - making too much of one kind of cell and not enough of another. Many types of human blood cancers involve a similar disruption in the expression of that same family of molecules.
Beginning to see the light
(PhysOrg.com) -- Scientists have detailed the active form of a protein which they hope will enhance our understanding of the molecular mechanisms of vision, and advance drug design.
A second career for a growth factor receptor: keeping nerve axons on target
Neurons constituting the optic nerve wire up to the brain in a highly dynamic way. Cell bodies in the developing retina sprout processes, called axons, which extend toward visual centers in the brain, lured by attractive cues and making U-turns when they take the wrong path. How they find targets so accurately is a central question of neuroscience today.
First gene associated with dry macular degeneration found
In a study that underscores the important role that individual genetic profiles will play in the development of new therapies for disease, a multi-institutional research team – led by Kang Zhang, MD, PhD professor of ophthalmology and human genetics at Shiley Eye Center at the University of California, San Diego, School of Medicine – has made two important discoveries related to age-related macular degeneration (AMD), the leading cause of blindness in adults over the age of 60.
Anti-HIV drugs reduce the cause of some forms of vision loss
A potential new therapeutic use for anti-HIV drugs known as protease inhibitors has been suggested by a team of researchers from Harvard Medical School, Boston, and Inserm U848, France, as a result of their work in a mouse model of retinal detachment.
MicroRNAs appear essential for retinal health
Retinas in newborn mice appear perfectly fine without any help from tiny bits of genetic material called microRNAs except for one thing — the retinas do not work.
Research defines eye cancer gene's role in retinal development
A genetic discovery led by scientists at St. Jude Children’s Research Hospital helps answer a long-standing mystery about the eyes of vertebrates, and may translate into a deeper understanding of how genes coordinate the complex process of eye formation and how a rare pediatric eye cancer progresses.
Gene therapy safety trial for childhood blindness under way
Three decades have passed since gene therapy pioneer William W. Hauswirth, Ph.D., and his colleagues at the University of Florida began work on a virus that could safely deliver corrective genes into living animals.

News discussion:

General Science news